All Work

Chris Lange

KemPharm Prepares for Secondary Offering

KemPharm expects to price its 3 million shares around last Thursday's closing price of $18.88, which would value the entire secondary offering at up to more than $65 million.

Chris Lange · 11 years ago

JPMorgan Wealth Management Subsidiaries Settle with SEC

The SEC has announced that two JPMorgan wealth management subsidiaries have agreed to pay $267 million and admit wrongdoing to settle charges regarding a failure to disclose conflicts of interest to clients.

Chris Lange · 11 years ago

SecureWorks Files for IPO

SecureWorks has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Chris Lange · 11 years ago

ReachLocal Skyrockets on Updated Outlook

ReachLocal raised its outlook for fourth-quarter 2015 adjusted EBITDA and announced a series of strategic actions to improve adjusted EBITDA and its liquidity position in order to provide a foundation for future growth.

Chris Lange · 11 years ago

Intercept Pharma Disappoints on FDA Extension

Intercept Pharmaceuticals announced that the FDA has extended the PDUFA date for its Priority Review of obeticholic acid in primary biliary cholangitis.

Chris Lange · 11 years ago

Pandora Wins on Copyright Royalty Board Rates

Pandora Media saw its shares shoot up early Thursday,following the announcement by the Copyright Royalty Board regarding the rates online streamers might pay for content.

Chris Lange · 11 years ago

Pier 1 Collapses on Guidance

Pier 1 Imports reported mixed fiscal third-quarter financial results Thursday after the markets closed on Wednesday.

Chris Lange · 11 years ago